ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Hong to Retire After 30 Years at MD Anderson

February 14, 2014

New Cancer Education Grant Program Guidelines, Developed

February 6, 1987

In Brief: Data Availability From Cancer Survey Presents Problems – Who Gets It first, Confidentiality

August 30, 1974

NCI Records Clear Flood Of Intervention For Man Accused Of Illegal Payoffs

February 3, 1978

Raub Briefs Councils On Women’s Health, Cost Containment

October 12, 1990

In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited

September 10, 1976